Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. The most common adverse effects were neutropenia (22%), vomiting (21%), diarrhea (20%) and inappetence (20%). Cyclophosphamide and vincristine were the agents that had caused more adverse gastrointestinal effects, while lomustine was the drug that had caused more hematologic effects.

  2. Of those responders who treated their dogs with isoxazolines (1,325) 80.1% reported adverse effects in their pets. Serious AE were noted in 4.55 to 14.79% of animals given isoxazolines (Tables 5 and 6 ).

  3. 25 lis 2013 · The Study Group recommends empirical application of immunosuppressive therapy for dogs with severe, persistent, or progressive glomerular disease in which there is evidence of an active immune-mediated pathogenesis on kidney biopsy and no identified contraindication to immunosuppressive therapy.

  4. Chemotherapy side effects can include anything from drug-specific toxicities (e.g., sterile hemorrhagic cystitis, cardiac toxicity, hepatotoxicity, and hypersensitivity reactions) to more general side effects that fall under the categories of gastrointestinal and hematologic. 1. Gastrointestinal Side Effects.

  5. 12 sie 2014 · This article will briefly discuss the diagnosis of MCTs in dogs and will summarize the literature in regards to the controversial topics surrounding the more aggressive form of this disease, with recommendations made based on published studies. Keywords: mitotic index. mastocytosis.

  6. Evidence of accelerated RBC lysis, such as hemo-globinemia/hemoglobinuria (intravascular hemolysis) or bilirubinemia/bilirubinuria. increase. TAble 1. IMMune-MeDIATeD HeMolyTIC AneMIA DIAgnosTIC overvIew. ngle test is definitively diagnostic for IMHA. Instead, evidence from vario. CATEGORY. History & Examina-tion. Laboratory Diagnostics.

  7. 22 mar 2021 · Development of high-quality liquid biopsy tests for dogs comparable to those currently available for human testing has the potential to revolutionize the detection, characterization, and management of cancer in pets. However, the challenges involved in such development are significant.